Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A4 | P31645 | 7/20 | 0.40 |
| ▸ | SLC6A2 | P23975 | 5/20 | 0.40 |
| ▸ | SLC6A3 | Q01959 | 5/20 | 0.40 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.38 |
| ▸ | IFNAR1 | P17181 | 1/20 | 0.38 |
| ▸ | PRMT3 | O60678 | 1/20 | 0.38 |
| ▸ | CARM1 | Q86X55 | 1/20 | 0.38 |
| ▸ | PRMT6 | Q96LA8 | 1/20 | 0.38 |
| ▸ | PRMT8 | Q9NR22 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | NPY1R | P25929 | 1/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | NPY2R | P49146 | 1/20 | 0.37 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.36 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.35 |
| ▸ | P4HB | P07237 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6299272 | 0.86 | SLC6A4 (0.38) | SLC6A4SLC6A2SLC6A3LMNAAPOBEC3G | |
| SCHEMBL9629224 | 0.85 | SLC6A4 (0.37) | SLC6A4SLC6A2SLC6A3LMNAAPOBEC3G | |
| SCHEMBL6298442 | 0.83 | SLC6A4 (0.36) | SLC6A4SLC6A2SLC6A3LMNAAPOBEC3G | |
| SCHEMBL7621965 | 0.82 | CHRM2 (0.46) | SLC6A4SLC6A2SLC6A3LMNAAPOBEC3G | |
| SCHEMBL11578406 | 0.80 | APOBEC3G (0.34) | APOBEC3G | |
| SCHEMBL5250559 | 0.80 | SLC6A4 (0.42) | SLC6A4SLC6A2SLC6A3LMNAAPOBEC3G | |
| SCHEMBL4574904 | 0.79 | TAAR1 (0.40) | SLC6A4SLC6A2SLC6A3LMNAALDH1A1 | |
| SCHEMBL4143747 | 0.76 | LMNA (0.44) | SLC6A4SLC6A2SLC6A3LMNAAPOBEC3G | |
| SCHEMBL588785 | 0.76 | APOBEC3G (0.48) | SLC6A4SLC6A2SLC6A3LMNAAPOBEC3G | |
| SCHEMBL2153441 | 0.76 | TAAR1 (0.54) | SLC6A4SLC6A2SLC6A3LMNAPRMT3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 59 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4545625-A1 | REMOVING TOXIC CHEMICALS FROM CONTAMINATED SURFACES | Guild Associates, Inc. (US) | 2025-04-30 | — | — | EP | disclosed |
| US-20250121237-A1 | Removing Toxic Chemicals from Contaminated Surfaces | Guild Associates Inc. (US) | 2025-04-17 | — | — | US | disclosed |
| CN-115772103-B | Method for preparing sulfoxide compound by catalytic oxidation of thioether | 华东师范大学 | 2025-04-01 | — | — | CN | disclosed |
| US-20240390851-A1 | PHOTOCATALYTIC AEROBIC OXIDATION OF YPERITE OR AN ANALOG THEREOF | COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) | 2024-11-28 | — | — | US | disclosed |
| EP-4426674-A1 | PHOTOCATALYTIC AEROBIC OXIDATION OF YPERITE OR AN ANALOG THEREOF | Commissariat à l'énergie atomique et aux énergies alternatives (FR) | 2024-09-11 | — | — | EP | disclosed |
| CN-112533934-B | Polyoxometallate compounds exhibiting bright emissions and methods of making same | 纳米2D材料有限公司 | 2024-07-19 | — | — | CN | disclosed |
| WO-2024114161-A1 | METHOD FOR PREPARING SULFOXIDE COMPOUND BY CATALYTICALLY OXIDIZING SULFIDE | 华东师范大学 | 2024-06-06 | — | — | WO | disclosed |
| WO-2023079111-A1 | PHOTOCATALYTIC AEROBIC OXIDATION OF YPERITE OR AN ANALOG THEREOF | COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) | 2023-05-11 | — | — | WO | disclosed |
| CN-115772103-A | Method for preparing sulfoxide compound by catalytic oxidation of thioether | 华东师范大学 | 2023-03-10 | — | — | CN | disclosed |
| CN-108623581-B | Method for preparing paninula compound | 中国海洋大学 | 2021-10-22 | — | — | CN | disclosed |
| WO-1998010286-A1 | METHODS FOR PROCESSING CHEMICAL COMPOUNDS HAVING REACTIVE FUNCTIONAL GROUPS | ISIS PHARMACEUTICALS, INC. (US) | 1998-03-12 | — | — | WO | disclosed |
| WO-1998005961-A1 | COMPOUNDS HAVING A PLURALITY OF NITROGENOUS SUBSTITUENTS | ISIS PHARMACEUTICALS, INC. (US) | 1998-02-12 | — | — | WO | disclosed |
| EP-0817787-A1 | NITROGENOUS MACROCYCLIC COMPOUNDS | ISIS PHARMACEUTICALS, INC. (US) | 1998-01-14 | — | — | EP | disclosed |
| WO-1996030377-A1 | NITROGENOUS MACROCYCLIC COMPOUNDS | ISIS PHARMACEUTICALS, INC. (US) | 1996-10-03 | — | — | WO | disclosed |
| EP-0235463-A2 | N-substituted-arylalkyl and arylalkylene piperidines as cardiovascular antihistaminic and antisecretory agents | A.H. ROBINS COMPANY, INCORPORATED (a Delaware corporation) (US) | 1987-09-09 | — | — | EP | disclosed |
| US-4524073-A | β-Lactam compounds | BEECHAM GROUP P.1.C. (GB) | 1985-06-18 | — | — | US | disclosed |
| US-4449005-A | REACTING A CHLOROETHYL SULFIDE AND QUATERNARY AMMONIUM OR QUATERNARY PHOSPHONIUM FLUORIDE TO PRODUCE A VINYL SULFIDE | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY (US) | 1984-05-15 | — | — | US | disclosed |
| EP-0101199-A1 | Beta-lactam compounds | BEECHAM GROUP PLC (GB) | 1984-02-22 | — | — | EP | disclosed |
| US-4113864-A | FUNGICIDES | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1978-09-12 | — | — | US | disclosed |
| US-4028438-A | INSECTICIDES, FUNGICIDES | SUMITOMO CHEMICAL COMPANY, LIMITED (JA) | 1977-06-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240390851-A1 | PHOTOCATALYTIC AEROBIC OXIDATION OF YPERITE OR AN ANALOG THEREOF | CYB5R3, CBR3, NOX4 | SLC6A4 995/4885SLC6A2 2464/4885SLC6A3 1031/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.